After treatment with VVLΔTKSTCΔN1L-mIL21, the number of potent anti-tumor CD4+ and CD8+ TCMs detected in the spleen was significantly increased, an effect that was further enhanced by combining treatment with α-PD1. This evidence concerns the gene CD8A and neoplasm.